Actively Recruiting Myasthenia Gravis Clinical TrialsKey Takeaways: Several clinical trials are currently enrolling participants with generalized myasthenia gravis (gMG) and ocular myasthenia gravis (OMG), exploring various mechanisms of action. These include studies evaluating new complement...reactionscomments
Differential Diagnosis of Myasthenia Gravis: Ruling Out MimickersKey Takeaways: While the hallmark symptoms of myasthenia gravis (MG) are fatigue and weakness, often affecting ocular, bulbar, facial, and limb muscles, a thorough differential diagnosis is crucial to ensure...reactionscomments
Myasthenia Gravis: The Road to Individualized TreatmentKey Takeaways: Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder characterized by muscle weakness and fatigue that worsens after activity and improves with rest. The underlying pathology involves autoantibodies...reactionscomments
Vaccinations and Myasthenia Gravis: Current RecommendationsKey Takeaways: Vaccination is a critical aspect of healthcare for all individuals, and it holds particular importance for patients with myasthenia gravis (MG). Due to potential immunosuppression from its treatments...reactionscomments
Your MG Patients' Top Questions: Practical Answers for Your PracticeKey Takeaways: Myasthenia gravis (MG) presents a unique set of challenges for patients. As healthcare providers (HCPs), understanding their most pressing concerns is paramount to delivering comprehensive and empathetic care...reactionscomments
Improving Quality of Life in MG: Targeted Symptom Management StrategiesKey Takeaways: While anti-cholinesterase inhibitors (AChEs) like pyridostigmine (Mestinon®) are often the first-line treatment for managing symptoms of myasthenia gravis (MG), they do not address all symptoms effectively in all...reactionscomments
